文献速递肝病

循环免疫细胞中独特的免疫代谢特征决定慢加急性肝衰竭的疾病结局

Distinct immunometabolic signatures in circulating immune cells define disease outcome in acute-on-chronic liver failure.
PubMed 文献 · Hepatology · 2024-05-16

本研究对慢加急性肝衰竭(ACLF)、急性失代偿(AD)肝硬化患者及健康个体的循环免疫细胞进行单细胞转录组测序,并结合免疫代谢与功能分析,揭示ACLF恢复者与未恢复者经典单核细胞存在两种不同状态,恢复者表现为免疫与应激耐受及氧化磷酸化代谢程序升高,未恢复者表现为炎症与应激反应基因表达升高及代谢活性减弱但功能增强。

要点

  • ACLF恢复者经典单核细胞高表达RETN、LGALS1等抗炎基因,并伴氧化磷酸化代谢程序升高。
  • ACLF未恢复者经典单核细胞高表达VIM、LGALS2、TREM1等炎症与应激反应基因,代谢活性减弱但功能增强。
  • ACLF恢复者淋巴群体同样呈现应激诱导的耐受状态、氧化磷酸化程序及激活减弱。

核心结论

  • 本研究识别出决定ACLF患者恢复或未恢复结局的不同免疫代谢细胞状态,为ACLF发病机制提供线索,并可能成为未来潜在治疗靶点。

研究设计与样本

  • 研究对ACLF患者、急性失代偿肝硬化患者及健康个体的循环免疫细胞进行单细胞转录组测序,并结合免疫代谢与功能验证实验进行分析。

主要发现

  • ACLF恢复者经典单核细胞以免疫与应激耐受相关转录本为特征,包括RETN和LGALS1等抗炎基因。
  • 代谢组学与功能验证实验提示ACLF恢复者经典单核细胞氧化磷酸化代谢程序升高且功能受损。
  • ACLF恢复者淋巴群体呈现共同的应激诱导耐受状态、氧化磷酸化程序及激活减弱。
  • ACLF未恢复者经典单核细胞炎症与应激反应基因如VIM、LGALS2和TREM1表达升高,代谢活性减弱而功能增强。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Acute-on-chronic liver failure (ACLF) is a complication of cirrhosis characterized by multiple organ failure and high short-term mortality. The pathophysiology of ACLF involves elevated systemic inflammation leading to organ failure, along with immune dysfunction that heightens susceptibility to bacterial infections. However, it is unclear how these aspects are associated with recovery and nonrecovery in ACLF. APPROACH AND RESULTS: Here, we mapped the single-cell transcriptome of circulating immune cells from patients with ACLF and acute decompensated (AD) cirrhosis and healthy individuals. We further interrogate how these findings, as well as immunometabolic and functional profiles, associate with ACLF-recovery (ACLF-R) or nonrecovery (ACLF-NR). Our analysis unveiled 2 distinct states of classical monocytes (cMons). Hereto, ACLF-R cMons were characterized by transcripts associated with immune and stress tolerance, including anti-inflammatory genes such as RETN and LGALS1 . Additional metabolomic and functional validation experiments implicated an elevated oxidative phosphorylation metabolic program as well as an impaired ACLF-R cMon functionality. Interestingly, we observed a common stress-induced tolerant state, oxidative phosphorylation program, and blunted activation among lymphoid populations in patients with ACLF-R. Conversely, ACLF-NR cMon featured elevated expression of inflammatory and stress response genes such as VIM , LGALS2 , and TREM1 , along with blunted metabolic activity and increased functionality. CONCLUSIONS: This study identifies distinct immunometabolic cellular states that contribute to disease outcomes in patients with ACLF. Our findings provide valuable insights into the pathogenesis of ACLF, shedding light on factors driving either recovery or nonrecovery phenotypes, which may be harnessed as potential therapeutic targets in the future.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Feio-Azevedo R, Boesch M, Radenkovic S, et al. Distinct immunometabolic signatures in circulating immune cells define disease outcome in acute-on-chronic liver failure. Hepatology. 2024. PMID: 38761406. doi:10.1097/HEP.0000000000000907

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。